Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03653143 · ClinicalTrials.gov registry record · NA

JASPER Intervention in Down Syndrome

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03653143 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03653143, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The goal of this study is to determine whether JASPER (Joint Attention, Symbolic Play, Engagement, Regulation), which is an intensive, targeted early behavioral intervention focused on a developmentally based approach for teaching joint engagement, joint attention, and play skills can improve behavioral / emotional regulation, social communication skills, and developmental trajectories in Down syndrome (DS). The investigators will also explore the potential use of EEG and event-related potentials (ERP) as outcome measures, as this approach may help elucidate mechanisms of change in behavior and development, and may help explain differences in development of social communication skills in individuals with DS. EEG and ERP measure may also help to predict treatment outcome.

Interventions

  • BEHAVIORAL JASPER

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-12-01
Est. Completion 2021-07-31
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT03653143

The ClinicalTrials.gov registry entry for NCT03653143 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which JASPER is the first listed.

NCT03653143 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03653143 about?

NCT03653143 is a clinical study titled "JASPER Intervention in Down Syndrome". The goal of this study is to determine whether JASPER (Joint Attention, Symbolic Play, Engagement, Regulation), which is an intensive, targeted early behavioral intervention focused on a developmentally based approach for teaching joint engagement, joint attention, and play skills can improve behavi...

What is the current status of trial NCT03653143?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-12-01. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT03653143?

The interventions under investigation include: JASPER (BEHAVIORAL).

Who is sponsoring clinical trial NCT03653143?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.